The Mexican consensus on the treatment of hepatitis C.

I Aiza-Haddad, A Ballesteros-Amozurrutia, O D Borjas-Almaguer, M Castillo-Barradas, G Castro-Narro,N Chávez-Tapia, R A Chirino-Sprung, L Cisneros-Garza, M Dehesa-Violante, J Flores-Calderón, A Flores-Gaxiola, I García-Juárez,M S González-Huezo,E I González-Moreno,F Higuera-de la Tijera, D Kershenobich-Stalnikowitz, E López-Méndez, R Malé-Velázquez, E Marín-López, J A Mata-Marín,N Méndez-Sánchez, R Monreal-Robles, R Moreno-Alcántar, L Muñoz-Espinosa, S Navarro-Alvarez, N Pavia-Ruz, A M Pérez-Ríos, J L Poo-Ramírez, M T Rizo-Robles,J F Sánchez-Ávila, R Sandoval-Salas,A Torre, R Torres-Ibarra, R Trejo-Estrada,J A Velarde-Ruiz Velasco, E Wolpert-Barraza,F Bosques-Padilla

Revista de Gastroenterología de México (English Edition)(2018)

引用 0|浏览13
暂无评分
摘要
The aim of the Mexican Consensus on the Treatment of HepatitisC was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, IFNectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitisC treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary.
更多
查看译文
关键词
Consensus,Direct-acting antiviral agents,Interferon-free regimens,Ribavirin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要